Global rotavirus surveillance: preparing for the introduction of rotavirus vaccines
"Rotavirus remains the most common cause of severe childhood diarrhea worldwide and of diarrheal mortality in poor countries. In 2003, the GAVI Alliance launched the Rotavirus Vaccine Program and the Accelerated Development and Introduction Plan to close the gap of access to rotavirus vaccines...
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago, IL
Univ. of Chicago Press
2009
|
| Schriftenreihe: | The journal of infectious diseases
Supplement ; 200,1 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Zusammenfassung: | "Rotavirus remains the most common cause of severe childhood diarrhea worldwide and of diarrheal mortality in poor countries. In 2003, the GAVI Alliance launched the Rotavirus Vaccine Program and the Accelerated Development and Introduction Plan to close the gap of access to rotavirus vaccines in industrialized and developing countries by generating data on rotavirus disease burden, projected impact, and cost-effectiveness of vaccination and by conducting clinical trials of existing vaccines in impoverished settings. By the end of 2008, rotavirus vaccines were licensed in >100 countries, although only 17 countries have introduced routine rotavirus vaccination. Increased uptake of the vaccine by countries with the highest childhood mortality will depend in part on a solid evidence base of estimated burden and cost of rotavirus illness. Since 2001, regional surveillance networks worldwide have generated burden and strain data from 196 sites in 59 countries. Among children aged <5 years who are hospitalized for severe diarrhea in different regions of the world, a regional median of 39% (range by country, 20%-73%) test positive for rotavirus. Rotavirus vaccines are a cost-effective intervention and may be cost saving with a GAVI Alliance subsidy from the health care perspective. Punctual vaccination and high coverage of populations at highest risk of mortality will maximize the impact of vaccination. Surveillance platforms will allow measurement of the rapid impact of rotavirus vaccine introduction on the heavy burden of rotavirus on child health worldwide." |
| Beschreibung: | 299 S. Ill., zahlr. graph. Darst., Kt. 28 cm |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV035817875 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 091110s2009 abd| |||| 00||| eng d | ||
| 035 | |a (OCoLC)463486992 | ||
| 035 | |a (DE-599)BVBBV035817875 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-29 |a DE-355 |a DE-188 | ||
| 245 | 1 | 0 | |a Global rotavirus surveillance |b preparing for the introduction of rotavirus vaccines |c guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar |
| 264 | 1 | |a Chicago, IL |b Univ. of Chicago Press |c 2009 | |
| 300 | |a 299 S. |b Ill., zahlr. graph. Darst., Kt. |c 28 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a The journal of infectious diseases : Supplement |v 200,1 | |
| 520 | 3 | |a "Rotavirus remains the most common cause of severe childhood diarrhea worldwide and of diarrheal mortality in poor countries. In 2003, the GAVI Alliance launched the Rotavirus Vaccine Program and the Accelerated Development and Introduction Plan to close the gap of access to rotavirus vaccines in industrialized and developing countries by generating data on rotavirus disease burden, projected impact, and cost-effectiveness of vaccination and by conducting clinical trials of existing vaccines in impoverished settings. By the end of 2008, rotavirus vaccines were licensed in >100 countries, although only 17 countries have introduced routine rotavirus vaccination. Increased uptake of the vaccine by countries with the highest childhood mortality will depend in part on a solid evidence base of estimated burden and cost of rotavirus illness. Since 2001, regional surveillance networks worldwide have generated burden and strain data from 196 sites in 59 countries. Among children aged <5 years who are hospitalized for severe diarrhea in different regions of the world, a regional median of 39% (range by country, 20%-73%) test positive for rotavirus. Rotavirus vaccines are a cost-effective intervention and may be cost saving with a GAVI Alliance subsidy from the health care perspective. Punctual vaccination and high coverage of populations at highest risk of mortality will maximize the impact of vaccination. Surveillance platforms will allow measurement of the rapid impact of rotavirus vaccine introduction on the heavy burden of rotavirus on child health worldwide." | |
| 610 | 2 | 4 | |a Rotavirus Vaccine Program |
| 650 | 4 | |a Rotaviruses | |
| 650 | 4 | |a Viral vaccines | |
| 650 | 4 | |a Gastroenteritis in children | |
| 650 | 4 | |a Gastroenteritis in children | |
| 650 | 4 | |a Immunization Programs |x economics | |
| 650 | 4 | |a Rotavirus Infections |x epidemiology | |
| 650 | 4 | |a Rotavirus Infections |x mortality | |
| 650 | 4 | |a Rotavirus Infections |x prevention & control | |
| 650 | 4 | |a Rotavirus Vaccines |x economics | |
| 650 | 4 | |a Rotaviruses | |
| 650 | 4 | |a Viral vaccines | |
| 650 | 4 | |a World Health | |
| 700 | 1 | |a Widdowson, Marc-Alain |e Sonstige |4 oth | |
| 830 | 0 | |a The journal of infectious diseases |v Supplement ; 200,1 |w (DE-604)BV005322771 |9 200,1 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018676684&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018676684 | ||
Datensatz im Suchindex
| _version_ | 1804140772606345216 |
|---|---|
| adam_text | Titel: Global rotavirus surveillance
Autor: Widdowson, Marc-Alain
Jahr: 2009
INTRODUCTION
SI Global Rota virus Surveillance: Determining the
Need and Measuring the Impact of Rotavirus
Vaccines
Marc-Alain Widdowson, Duncan Steele, Jazmin Vojdani, John Wecker,
and Umesh Parashar
GLOBAL
S9 Global Mortality Associated with Rotavirus
Disease among Children in 2004
Umesh D. Parashar, Anthony Burton, Claudio Lanata,
Cynthia Boschi-Pinto, Kenji Shibuya, Duncan Steele,
Maureen Birmingham, and Roger I. Glass
S16 Economic Costs of Rotavirus Gastroenteritis and
Cost-Effectiveness of Vaccination in Developing
Countries
Richard D. Rheingans, Lynn Antil, Robert Dreibelbis,
Laura Jean Podewils, Joseph S. Bresee, and Umesh D. Parashar
S28 Rotavirus Vaccination: Cost-Effectiveness and
Impact on Child Mortality in Developing
Countries
Deborah Atherly, Robert Dreibelbis, Umesh D. Parashar, Carol Levin,
John Wecker, and Richard D. Rheingans
S39 Oral Rotavirus Vaccines: How Well Will They
Work Where They Are Needed Most?
Manish Patel, Andi L. Shane, Umesh D. Parashar, Baoming Jiang,
Jon R. Gentsch, and Roger I. Glass
S49 Projected Impact of the New Rotavirus
Vaccination Program on Hospitalizations for
Gastroenteritis and Rotavirus Disease among US
Children 5 Years of Age during 2006-2015
Aaron T. Curns, Fanny Coffin, John W. Glasser, Roger I. Glass, and
Umesh D. Parashar
S57 A Review of Rotavirus Infection in and
Vaccination of Human Immunodeficiency Virus-
Infected Children
A. Duncan Steele, Nigel Cunliffe, John Tumbo, Shabir A. Madhi,
Beatrice De Vos, and Alain Bouckenooghe
S63 Rotavirus Vaccines for Infants in Developing
Countries in Africa and Asia: Considerations
from a World Health Organization-Sponsored
Consultation
A. Duncan Steele, Manish Patel, Umesh D. Parashar, John C. Victor,
Teresa Aguado, and Kathleen M. Neuzil
AFRICA
S70 Epidemiology of Rotavirus Gastroenteritis among
Children 5 Years of Age in Morocco during 1
Year of Sentinel Hospital Surveillance, June
2006-May 2007
Mohammed Benhafid, Mohammed Youbi, John D. Klena,
Jon R. Gentsch, Nadia Teleb, Marc-Alain Widdowson, and
Rajae ElAouad
S76 Rotavirus Disease Burden and Impact and Cost-
Effectiveness of a Rotavirus Vaccination Program
in Kenya
Jacqueline E. Tate, Richard D. Rheingans, Ciara E. O Reilly,
Benson Obonyo, Deron C. Burton, Jeffrey A. Tornheim, Kubaje Adazu,
Peter Jaron, Benjamin Ochieng, Tara Kerin, Lisa Calhoun, Mary Hamel,
Kayla Laserson, Robert F. Breiman, Daniel R. Feikin, Eric D. Mintz, and
Marc-Alain Widdowson
S85 How Much Could Rotavirus Vaccines Reduce
Diarrhea-Associated Mortality in Northern
Ghana? A Model to Assess Impact
Melissa L. Arvay, Aaron T. Curns, Sophia Terp, George Armah,
Peter Wontuo, Umesh D. Parashar, Fred Binka, Roger I. Glass, and
Marc-Alain Widdowson
S92 Cost-Benefit Analysis of a Rotavirus
Immunization Program in the Arab Republic of
Egypt
Omayra Ortega, Nasr El-Sayed, John W. Sanders, Zakaria Abd-Rabou,
Lynn Antil, Joseph Bresee, Adel Mansour, Ibrahim Adib,
Isabelle Nahkla. and Mark S. Riddle
THE AMERICAS
S99 G and P Types of Circulating Rotavirus Strains
in the United States during 1996-2005: Nine
Years of Prevaccine Data
Jon R. Gentsch, Jennifer J. Hull, Elizabeth N. Teel, Tara K. Kerin,
Molly M. Freeman, Mathew D. Esona, Dixie D. Griffin,
Brittany P. Bielfelt-Krall, Krisztian Banyai, Baoming Jiang,
Margaret M. Cortese, Roger I. Glass, Umesh D. Parashar, and the
collaborating laboratories of the National Rotavirus Strain Surveillance
System
S106 Rotavirus Gastroenteritis in Children in 4
Regions in Brazil: A Hospital-Based Surveillance
Study
Veridiana Munford, Alfredo Elias Gilio, Eloisa Correa de Souza,
Debora Morais Cardoso, Divina das Dores de Paula Cardoso,
Ana Maria Tavares Borges, Paulo Sergio Sucasas da Costa,
Irene Angela Melo Melgago, Humberto Rosa,
Paulo Roberto Antonacci Carvalho, Marcelo Zubaran Goldani,
Edson Duarte Moreira, Jr., Ciria Santana, Antoine El Khoury,
Fabio Ikedo, and Maria Lucia Racz
SI 14 Cost-Effectiveness of Rotavirus Vaccination in
Peru
Andrew D. Clark, Damian G. Walker, N. Rocio Mosqueira,
Mary E. Penny, Claudio F. Lanata, Julia Fox-Rushby, and
Colin F. B. Sanderson
S125 Uptake of Rotavirus Vaccine and National Trends
of Acute Gastroenteritis among Children in
Nicaragua
Maribel Orozco, Joshua Vasquez, Cristina Pedreira, Lucia Helena De
Oliveira, Juan Jose Amador, Omar Malespin, Jon Andrus,
Jacqueline Tate, Umesh Parashar, and Manish Patel
S131 Sentinel Hospital Surveillance for Rotavirus in
Latin American and Caribbean Countries
Lucia Helena de Oliveira, M. Carolina Danovaro-Holliday,
Jon Kim Andrus, Ana Maria Bispo de Fillipis, Jon Gentsch,
Cuauhtemoc Ruiz Matus, and Marc-Alain Widdowson, on behalf of
the Rotavirus Surveillance Network
ASIA
SI40 A Retrospective Evaluation of Hospitalizations
for Acute Gastroenteritis at 2 Sentinel Hospitals
in Central Japan to Estimate the Health Burden
of Rotavirus
Hajime Kamiya, Takashi Nakano, Masakazu Inoue, Hitoshi Kamiya,
Thura T. Abd, Manish Patel, Walter A. Orenstein, and
Umesh D. Parashar
S147 Multicenter, Hospital-Based Surveillance of
Rotavirus Disease and Strains among Indian
Children Aged 5 Years
Gagandeep Kang, Rashmi Arora, Shobha D. Chitambar,
Jagdish Deshpande, M. D. Gupte, Madhuri Kulkarni, Trilok N. Naik,
Dipali Mukherji, S. Venkatasubramaniam, Jon R. Gentsch,
Roger I. Glass, and Umesh D. Parashar, for the Indian Rotavirus Strain
Surveillance Network
S154 Rotavirus Gastroenteritis in Uzbekistan:
Implications for Vaccine Policy in Central Asia
Elmira T. Flem, Erkin Musabaev. Rivojiddin Juraev, Tara Kerin,
Jon Gentsch, Roger I. Glass, and Joseph S. Bresee
S160 Epidemiology of Rotavirus Diarrhea in Mongolia
and Sri Lanka, March 2005-February 2007
Batmunkh Nyambat. Sengee Gantuya, Ranjitn Batuwanthudawe,
Pushpa R. Wijesinghe, Nihal Abeysinghe, Geethani Galagoda,
Carl Kirkwood, Nada Bogdanovic-Sakran, Jung Oak Kang, and
Paul E. Kilgore
S167 Hospital-Based Surveillance of Rotavirus
Diarrhea in the People s Republic of China,
August 2003-July 2007
Zhao-jun Duan, Na Liu, Su-hua Yang, Jing Zhang, Li-Wei Sun,
Jing-Yu Tang, Yu Jin, Zeng-Qing Du, Jin Xu, Qing-bin Wu, Zhi-li Tong,
Si-tang Gong, Yuan Qian, Jian-min Ma, Xu-chun Liao,
Marc-Alain Widdowson, Baoming Jiang, and Zhao-Yin Fang
S174 The Burden of Hospitalizations and Clinic Visits
for Rotavirus Disease in Children Aged 5 Years
in the Philippines
Celia C. Carlos, Marianette I Inobaya, Joseph S. Bresee,
Marietta L. Lagrada, Agnettah M. Olorosa, Carl D. Kirkwood, and
Marc-Alain Widdowson
SI82 Molecular Epidemiology of Rotavirus Diarrhea
among Children Aged 5 Years in Nepal:
Predominance of Emergent G12 Strains during 2
Years
Jeevan Bahadur Sherchand, Osamu Nakagomi, Winifred Dove,
Toyoko Nakagomi, Michiyo Yokoo, Basu Dev Pandey, Luis E. Cuevas,
C. Anthony Hart, and Nigel A. Cunliffe
SI88 Burden of Severe Rotavirus Diarrhea in
Indonesia
Yati Soenarto, Abu. T. Aman, Achirul Bakri, Herman Waluya,
Agus Firmansyah, Muzal Kadim, lesje Martiza, Dwi Prasetyo,
Nenny S. Mulyani, Titis Widowati, Soetjiningsih,
I. Putu Gede Kan/ana, Wayan Sukardi, Joseph Bresee, and
Marc-Alain Widdowson
S195 Costs of Diarrheal Disease and the Cost-
Effectiveness of a Rotavirus Vaccination Program
in Kyrgyzstan
Elmira I Flem, Benat Latipov, Zuridin S. Nurmatov, Yiting Xue,
Kaliya T. Kasymbekova, and Bichard D. Bheingans
EUROPE
S203 Rotavirus Burden among Children in the Newly
Independent States of the Former Union of
Soviet Socialist Republics: Literature Review and
First-Year Results from the Rotavirus Surveillance
Network
Badmila Mirzayeva, Margaret M. Cortese, Liudmila Mosina,
Bobin Biellik, Andrei Lobanov, Lyudmila Chernyshova,
Marina Lashkarashvili, Soibnazar Turkov, Miren Iturriza-Gomara,
Jim Gray, Umesh D. Parashar, Duncan Steele, Nedret Emiroglu, and
members of the Botavirus Surveillance Network
S215 Rotavirus Surveillance in Europe, 2005-2008:
Web-Enabled Reporting and Real-Time Analysis
of Genotyping and Epidemiological Data
M. Iturriza-G6mara, T. Dallman, K. Banyai, B. Bottiger, J. Buesa,
S. Diedrich, L. Fiore, K. Johansen, N. Korsun, A. Kroneman,
M. Lappalainen, B. LSszIo, L. Maunula, J. Matthinjnssens, S. Midgley,
Z. Mladenova, M. Poljsak-Prijatelj, P. Pothier, F. M. Buggeri,
A. Sanchez-Fauquier, E. Schreier, A. Steyer, I. Sidaraviciute,
A. N. Tran, V. Usonis, M. Van Banst, A. de Bougemont, and J. Gray
S222 Trends in the Epidemiology of Human G1P[8]
Rotaviruses: A Hungarian Study
Krisztian Banyai, Jon R. Genlsch, Vito Martella, Agnes Bogdan,
Viktoria Havasi, Peter Kisfali, Aliz Szabrj, Nona Mihaly, P6ter Molnar,
Bela Melegh, and Gyorgy Sziics
S228 Hospital-Based Surveillance of Rotavirus and
Other Viral Agents of Diarrhea in Children and
Adults in Russia, 2005-2007
A. T. Podkolzin, E. B. Fenske, N. Yu Abramycheva, G. A. Shipulin,
0. I. Sagalova, V. N. Mazepa, G. N. Ivanova, A. V. Semena,
Z. G. Tagirova, M. N. Alekseeva, V. P. Molochny, U. D. Parashar,
J. Vinje, V. V. Maleev, R. I. Glass, and V. I. Pokrovsky
S234 Multicenter Prospective Study on the Burden of
Rotavirus Gastroenteritis in Turkey, 2005-2006: A
Hospital-Based Study
Mehmet Ceyhan, Emre Alhan, Nuran Salman, Zafer Kurugol,
Inci Yildirim, Umit Celik, Melike Keser, Guldane Koturoglu,
Hasan Tezer, Emine Kuset Bulbul, Metin Karabocuoglu, Oya Halicioglu,
Sameh Anis, and Robert Pawinski
MIDDLE EAST
S239 Emergence and Characterization of Human
Rotavirus G9 Strains in Tunisia
Anissa Chouikha, Imene Fodha, Lamjed Bouslama, Mouna Ben Had)
Fredj, Samir Jaoua, Noureddine Boujaafar, Abdelhalim Trabelsi, and
Andrew Duncan Steele
S244 Sentinel Hospital-Based Surveillance of Rotavirus
Diarrhea in Iran
A. Eesteghamati, M. Gouya, A. Keshtkar, L. Najafi, M. R. Zali.
M Sanaei, F. Yaghini, H. el Mohamady, M. Patel, J. D. Klena, and
N. Teleb
S248 Considerations for Introduction of a Rotavirus
Vaccine in Oman: Rotavirus Disease and
Economic Burden
S. A. Al Awaidy, S. Bawikar, S. Al Busaidy, S. Baqiani, I. Al Abedani,
R. Varghese, H. S. Abdoan, H. Al Abdoon, S. Bhatnagar, K. S. Al
Hasini, P. Mohan, S. Shah, E. Elamir, J. Klena, S. F. Ahmed, N. Teleb,
U. Parashar, and M. M. Patel
S254 Incidence, Characteristics, and Economic Burden
of Rotavirus Gastroenteritis Associated with
Hospitalization of Israeli Children 5 Years of
Age, 2007-2008
Khitam Muhsen, Lester Shulman, Uri Rubinstein, Eias Kasem,
Adi Kremer, Sophy Goren, liana Zilberstein, Gabby Chodick,
Moshe Ephros. and Dani Cohen, for the TAU-HCLV Rota Study Group
INTUSSUSCEPTION
S264 Underestimates of Intussusception Rates among
US Infants Based on Inpatient Discharge Data:
Implications for Monitoring the Safety of
Rotavirus Vaccines
Margaret M. Cortese, Mary Allen Staat, Geoffrey A. Weinberg,
Kathryn Edwards, Marilyn A. Rice, Peter G. Szilagyi, Caroline B. Hall,
Daniel C. Payne, and Umesh D. Parashar
S271 Intussusception Surveillance in a Rural
Demographic Surveillance Area in Bangladesh
Khalequ Zaman, Robert F. Breiman, Md. Yunus, Shams E. Arifeen,
Asheque Mahmud, H. R. Chowdhury, and Stephen P. Luby
S277 Population-Based Incidence of Intussusception
and a Case-Control Study to Examine the
Association of Intussusception with Natural
Rotavirus Infection among Indian Children
Rajiv Bahl, Manju Saxena, Nita Bhandari, Sunita Taneja,
Meera Mathur, Umesh D. Parashar, Jon Gentsch, Wun-Ju Shieh,
Sherif R. Zaki, Roger Glass, Maharaj K. Bhan, and the Delhi
Intussusception Study Hospital Group
POST-VACCINE INTRODUCTION
S282 Assessment of Postlicensure Safety of Rotavirus
Vaccines, with Emphasis on Intussusception
Julie E. Bines, Manish Patel, and Umesh Parashar
S291 Assessing the Effectiveness and Public Health
Impact of Rotavirus Vaccines after Introduction
in Immunization Programs
Manish M. Patel and Umesh D. Parashar
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV035817875 |
| ctrlnum | (OCoLC)463486992 (DE-599)BVBBV035817875 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03377nam a2200445 cb4500</leader><controlfield tag="001">BV035817875</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">091110s2009 abd| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)463486992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035817875</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Global rotavirus surveillance</subfield><subfield code="b">preparing for the introduction of rotavirus vaccines</subfield><subfield code="c">guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, IL</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">299 S.</subfield><subfield code="b">Ill., zahlr. graph. Darst., Kt.</subfield><subfield code="c">28 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">The journal of infectious diseases : Supplement</subfield><subfield code="v">200,1</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"Rotavirus remains the most common cause of severe childhood diarrhea worldwide and of diarrheal mortality in poor countries. In 2003, the GAVI Alliance launched the Rotavirus Vaccine Program and the Accelerated Development and Introduction Plan to close the gap of access to rotavirus vaccines in industrialized and developing countries by generating data on rotavirus disease burden, projected impact, and cost-effectiveness of vaccination and by conducting clinical trials of existing vaccines in impoverished settings. By the end of 2008, rotavirus vaccines were licensed in >100 countries, although only 17 countries have introduced routine rotavirus vaccination. Increased uptake of the vaccine by countries with the highest childhood mortality will depend in part on a solid evidence base of estimated burden and cost of rotavirus illness. Since 2001, regional surveillance networks worldwide have generated burden and strain data from 196 sites in 59 countries. Among children aged <5 years who are hospitalized for severe diarrhea in different regions of the world, a regional median of 39% (range by country, 20%-73%) test positive for rotavirus. Rotavirus vaccines are a cost-effective intervention and may be cost saving with a GAVI Alliance subsidy from the health care perspective. Punctual vaccination and high coverage of populations at highest risk of mortality will maximize the impact of vaccination. Surveillance platforms will allow measurement of the rapid impact of rotavirus vaccine introduction on the heavy burden of rotavirus on child health worldwide."</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">Rotavirus Vaccine Program</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotaviruses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastroenteritis in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastroenteritis in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunization Programs</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotavirus Infections</subfield><subfield code="x">epidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotavirus Infections</subfield><subfield code="x">mortality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotavirus Infections</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotavirus Vaccines</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rotaviruses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">World Health</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Widdowson, Marc-Alain</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">The journal of infectious diseases</subfield><subfield code="v">Supplement ; 200,1</subfield><subfield code="w">(DE-604)BV005322771</subfield><subfield code="9">200,1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018676684&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018676684</subfield></datafield></record></collection> |
| id | DE-604.BV035817875 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:05:17Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018676684 |
| oclc_num | 463486992 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29 DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-19 DE-BY-UBM DE-29 DE-355 DE-BY-UBR DE-188 |
| physical | 299 S. Ill., zahlr. graph. Darst., Kt. 28 cm |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Univ. of Chicago Press |
| record_format | marc |
| series | The journal of infectious diseases |
| series2 | The journal of infectious diseases : Supplement |
| spelling | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar Chicago, IL Univ. of Chicago Press 2009 299 S. Ill., zahlr. graph. Darst., Kt. 28 cm txt rdacontent n rdamedia nc rdacarrier The journal of infectious diseases : Supplement 200,1 "Rotavirus remains the most common cause of severe childhood diarrhea worldwide and of diarrheal mortality in poor countries. In 2003, the GAVI Alliance launched the Rotavirus Vaccine Program and the Accelerated Development and Introduction Plan to close the gap of access to rotavirus vaccines in industrialized and developing countries by generating data on rotavirus disease burden, projected impact, and cost-effectiveness of vaccination and by conducting clinical trials of existing vaccines in impoverished settings. By the end of 2008, rotavirus vaccines were licensed in >100 countries, although only 17 countries have introduced routine rotavirus vaccination. Increased uptake of the vaccine by countries with the highest childhood mortality will depend in part on a solid evidence base of estimated burden and cost of rotavirus illness. Since 2001, regional surveillance networks worldwide have generated burden and strain data from 196 sites in 59 countries. Among children aged <5 years who are hospitalized for severe diarrhea in different regions of the world, a regional median of 39% (range by country, 20%-73%) test positive for rotavirus. Rotavirus vaccines are a cost-effective intervention and may be cost saving with a GAVI Alliance subsidy from the health care perspective. Punctual vaccination and high coverage of populations at highest risk of mortality will maximize the impact of vaccination. Surveillance platforms will allow measurement of the rapid impact of rotavirus vaccine introduction on the heavy burden of rotavirus on child health worldwide." Rotavirus Vaccine Program Rotaviruses Viral vaccines Gastroenteritis in children Immunization Programs economics Rotavirus Infections epidemiology Rotavirus Infections mortality Rotavirus Infections prevention & control Rotavirus Vaccines economics World Health Widdowson, Marc-Alain Sonstige oth The journal of infectious diseases Supplement ; 200,1 (DE-604)BV005322771 200,1 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018676684&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines The journal of infectious diseases Rotavirus Vaccine Program Rotaviruses Viral vaccines Gastroenteritis in children Immunization Programs economics Rotavirus Infections epidemiology Rotavirus Infections mortality Rotavirus Infections prevention & control Rotavirus Vaccines economics World Health |
| title | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines |
| title_auth | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines |
| title_exact_search | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines |
| title_full | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar |
| title_fullStr | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar |
| title_full_unstemmed | Global rotavirus surveillance preparing for the introduction of rotavirus vaccines guest ed.: Marc-Alain Widdowson ; A. Duncan Steele ; Umesh D. Parashar |
| title_short | Global rotavirus surveillance |
| title_sort | global rotavirus surveillance preparing for the introduction of rotavirus vaccines |
| title_sub | preparing for the introduction of rotavirus vaccines |
| topic | Rotavirus Vaccine Program Rotaviruses Viral vaccines Gastroenteritis in children Immunization Programs economics Rotavirus Infections epidemiology Rotavirus Infections mortality Rotavirus Infections prevention & control Rotavirus Vaccines economics World Health |
| topic_facet | Rotavirus Vaccine Program Rotaviruses Viral vaccines Gastroenteritis in children Immunization Programs economics Rotavirus Infections epidemiology Rotavirus Infections mortality Rotavirus Infections prevention & control Rotavirus Vaccines economics World Health |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018676684&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV005322771 |
| work_keys_str_mv | AT widdowsonmarcalain globalrotavirussurveillancepreparingfortheintroductionofrotavirusvaccines |